Lydia Eccersley

703 total citations
9 papers, 28 citations indexed

About

Lydia Eccersley is a scholar working on Hematology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lydia Eccersley has authored 9 papers receiving a total of 28 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Lydia Eccersley's work include Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (3 papers) and HIV/AIDS drug development and treatment (3 papers). Lydia Eccersley is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (3 papers) and HIV/AIDS drug development and treatment (3 papers). Lydia Eccersley collaborates with scholars based in United Kingdom, Australia and Poland. Lydia Eccersley's co-authors include Zhongjun Xia, Christopher McNamara, Paweł Robak, Claudio Cerchione, Sumita Roy–Ghanta, A. Victor Hoffbrand, Christopher Wård, Astrid McKeown, Malcolm H.A. Rustin and Vânia Hungria and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Lydia Eccersley

9 papers receiving 28 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lydia Eccersley United Kingdom 3 20 17 13 5 5 9 28
Marie Odile Petillon France 4 29 1.4× 21 1.2× 13 1.0× 9 1.8× 3 0.6× 4 37
Roberto Ovilla Mexico 4 23 1.1× 15 0.9× 12 0.9× 13 2.6× 3 0.6× 9 36
Edward A. Belter United States 3 17 0.8× 25 1.5× 9 0.7× 2 0.4× 9 1.8× 3 39
M Silva Spain 1 14 0.7× 8 0.5× 9 0.7× 7 1.4× 8 1.6× 2 22
Eva A. Coenen Netherlands 5 22 1.1× 25 1.5× 10 0.8× 6 1.2× 4 0.8× 6 42
Juan Bargay Spain 3 33 1.6× 17 1.0× 12 0.9× 9 1.8× 4 0.8× 4 38
Daniela V. Wenge United States 6 37 1.9× 38 2.2× 13 1.0× 5 1.0× 4 0.8× 12 60
Debbie Hastings United States 3 21 1.1× 20 1.2× 13 1.0× 7 1.4× 3 0.6× 7 30
Marta Reinoso Segura Spain 4 44 2.2× 29 1.7× 22 1.7× 3 0.6× 3 0.6× 5 44
Olga Shvetz Israel 3 22 1.1× 19 1.1× 16 1.2× 4 0.8× 2 0.4× 6 26

Countries citing papers authored by Lydia Eccersley

Since Specialization
Citations

This map shows the geographic impact of Lydia Eccersley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Eccersley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Eccersley more than expected).

Fields of papers citing papers by Lydia Eccersley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Eccersley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Eccersley. The network helps show where Lydia Eccersley may publish in the future.

Co-authorship network of co-authors of Lydia Eccersley

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Eccersley. A scholar is included among the top collaborators of Lydia Eccersley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Eccersley. Lydia Eccersley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
3.
4.
5.
6.
7.
Mateos, María‐Victoria, Paweł Robak, Marek Hus, et al.. (2024). Results from the randomized phase III DREAMM-7 study of belantamab mafodotin (belamaf) + bortezomib, and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 42(36_suppl). 439572–439572. 12 indexed citations
8.
Eccersley, Lydia, John G. Gribben, Simon Hallam, et al.. (2021). Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience. British Journal of Haematology. 193(2). 420–423. 4 indexed citations
9.
Eccersley, Lydia, A. Victor Hoffbrand, Malcolm H.A. Rustin, & Christopher McNamara. (2009). Paraneoplastic pemphigus associated with systemic mastocytosis. American Journal of Hematology. 84(12). 847–848. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Odile Petillon Breakdown of academic impact, for papers by Roberto Ovilla Breakdown of academic impact, for papers by Edward A. Belter Breakdown of academic impact, for papers by M Silva Breakdown of academic impact, for papers by Eva A. Coenen Breakdown of academic impact, for papers by Juan Bargay Breakdown of academic impact, for papers by Daniela V. Wenge Breakdown of academic impact, for papers by Debbie Hastings Breakdown of academic impact, for papers by Marta Reinoso Segura Breakdown of academic impact, for papers by Olga Shvetz
Rankless by CCL
2026